基于 Th17/Treg 免疫失衡研究茯苓四逆汤 对脓毒症心肌病患者的影响
CSTR:
作者:
作者单位:

〔北京中医药大学深圳医院(龙岗),广东 深圳 518172〕

作者简介:

黄亚秀,男,主治医师,主要从事中医治疗危重症患者的救治工作。

通讯作者:

中图分类号:

R 541

基金项目:

深圳市科创委计划项目资助课题(JCYJ20180302150228829)


Effect of Fuling Sini Decoction on Patients with Septic Cardiomyopathy Based on Th17/Treg Immune Imbalance
Author:
Affiliation:

(Shenzhen Hospital of Beijing University of Chinese Medicine (Longgang), Guangdong Shenzhen 518172)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:从辅助性 T 细胞 17(Th17)/ 调节性 T 细胞(Treg)免疫失衡角度研究茯苓四逆汤对脓毒性心肌病 患者免疫调节的影响。 方法:选取北京中医药大学深圳医院(龙岗)2018 年 3 月至 2021 年 2 月期间重症加强护理病房 (ICU)收治的脓毒症合并脓毒性心肌病患者 56 例,使用随机数字表法随机分为对照组和观察组,各 28 例。对照组采用 常规治疗,观察组在对照组基础上给予茯苓四逆汤口服,疗程 7 d。比较两组患者治疗前后的急性生理和慢性健康状况评 分(APACHE– Ⅱ)、全身感染相关器官功能衰竭评分(SOFA)、中医症候积分以及治疗前后白细胞介素 –6(IL–6)、 IL–10、肌钙蛋白 I(cTnI)、氨基末端脑钠肽前体(NT–proBNP)、CD4+ /CD8+、Th17/Treg,统计 ICU 停留时间及 28 d 病死率以及治疗总有效率。 结果:观察组患者治疗总有效率为 82.14 %,高于对照组的 71.14 %,差异具有统计学意义 (P < 0.05);治疗前两组患者 IL–10、IL–6、CD4+ /CD8+、Th17/Treg 水平比较,差异无统计学意义(P > 0.05);治疗后 两组患者的 IL–10、CD4+ /CD8+ 均不同程度升高,IL–6、Th17/Treg 不同程度下降,且观察组患者 IL–10、CD4+ /CD8+ 高于对 照组,IL–6、Th17/Treg 低于对照组,差异具有统计学意义(P < 0.05)。治疗前两组患者的 cTnI、NT–proBNP 水平比较, 差异无统计学意义(P > 0.05);治疗后两组患者的 cTnI、NT–proBNP 水平均不同程度下降,且观察组低于对照组,差异 具有统计学意义(P < 0.05)。观察组患者 28 d 病死率为 5 例(17.86 %),与对照组的 6 例(21.43 %)比较,差异无统 计学意义(P > 0.05)。观察组患者 ICU 住院时间为(6.84 ± 1.53)d,短于对照组的(8.25 ± 1.69)d,差异具有统计学意 义(P < 0.05)。 结论:茯苓四逆汤能通过免疫调节,改善脓毒性心肌病患者的免疫失衡,抑制炎症反应,保护心肌,改 善短期预后。

    Abstract:

    〔Abstract〕 Objective Study on the effect of Fuling Sini Decoction on immune regulation of patients with septiccardiomyopathy from the perspective of Th17/Treg immune imbalance. Method 56 patients with septic cardiomyopathy were randomly divided into treatment group and control group 28 cases respectively. The control group was treated with routine treatment. The treatment group was given poring Sini Decoction orally on the basis of the control group for 7 days. The acute physiological and chronic health status scores (apache- Ⅱ), systemic infection related organ failure score(sofa), TCM syndrome score were compared in the two groups before and after treatment. The IL-6, IL-10, cTnI, NT-proBNP, CD4+ /CD8+ , Th17/Treg were compared in the two groups before and after treatment. The ICU stay time and mortality rate at 28d were statistically analyzed. Results Seven days after treatment, the TCM symptom score, Apache- Ⅱ score and SOFA score of the two groups were signifi cantly lower than those before treatment, and the improvement of the treatment group was significantly better than that of the control group (P < 0.05); IL-10 and CD4+ /CD8+ of the treatment group were signifi cantly higher than those of the control group, while IL-6 and Th17/Treg of the treatment group were signifi cantly lower than those of the control group, and the differences were statistically signifi cant (P < 0.05). Before treatment, the cTnI and NT-proBNP levels of the two groups of patients were not statistically different (P> 0.05); after treatment, the cTnI and NT-proBNP levels of the two groups of patients decreased to varying degrees, and the observation group was lower than the control group. The difference was statistically signifi cant (P < 0.05).The 28-day case fatality rate of the observation group was 5 cases (17.86%), compared with 6 cases (21.43%) in the control group, the difference was not statistically signifi cant (P > 0.05).The length of ICU stay in the observation group was (6.84 ± 1.53) days, which was shorter than (8.25 ± 1.69) days in the control group, and the difference was statistically signifi cant (P < 0.05). Conclusion Fuling Sini Decoction can improve immune imbalance, inhibit infl ammatory reaction, protect myocardium and improve short-term prognosis of patients with septic cardiomyopathy through immune regulation.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-04-11
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-10-29
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭